How many studies have been conducted on Dihydroergocryptine?

BiohacksAI has indexed 257 PubMed studies on Dihydroergocryptine, including 13 randomized controlled trials (RCTs). 21% of studies involve human subjects.

What are the main research areas for Dihydroergocryptine?

The primary research domains for Dihydroergocryptine are 🧠 Focus & Attention, 🌤️ Mood & Depression, 🫁 Liver & Detox. This is based on analysis of 257 PubMed studies using the BiohacksAI evidence platform.

Dihydroergocryptine

A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha position of the molecule.

257+ PubMed studies analyzed · 13 RCTs · Evidence Score: 45.6

Research Domains

Dihydroergocryptine has been studied across 19 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🫁 Liver & Detox, 🧠 Neuroprotection, 🧬 Hormones. The primary research focus is 🧠 Focus & Attention with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dihydroergocryptine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Dihydroergocryptine is generated deterministically from 257 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.